Merck's Richard Clark - CEO Pay
Richard Clark - Merck
Total Compensation: $14.5M
2007 Revenue: $24.2B
2006 Revenue: $22.6B
Change: 7%
Details: 2007 was a great year for Merck, with the company making significant progress on the five year turnaround plan enacted after the Vioxx scandal. The company's good fortunes led to an 80 percent hike in compensation for CEO Richard Clark. It included $1.62 million in base pay, 37 percent more than 2006 levels, and $8.23 million in stock and options grants. In addition, Clark got $4.31 million in incentive pay, plus about $360,000 worth of miscellaneous items like retirement-plan matching funds ($10,125), a home security system ($51,024), and commuting costs ($18,686).
Merck News:
Merck chief got 80% pay hike
Analysts cheer signs of turnaround at Merck
Merck touts reorganization effort
Fortune scolds Merck for "risky" programs
Merck presents pipeline update to analysts
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment